Swati P. Jalgaonkar

Swati P. Jalgaonkar

Auto-generated profile, based on publicly available information

Swati P. Jalgaonkar

Department of Molecular and Cellular Biochemistry, 2Integrated Biomedical Graduate Program, 3Molecular, Cellular, and Developmental Biology Program, 4Department of Pathology, 5Comprehensive Cancer Center, and 6The Ohio State Biochemistry Program, The Ohio State University, Columbus, Ohio, USA. 7The Kinghorn Cancer Center and Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia. 8Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2009 in Stem Cells
Verified
Journal Article
Open access
PDF file
NKNawneet K. Kurrey
Nawneet K. Kurrey
SJSwati P. Jalgaonkar
Swati P. Jalgaonkar
AJAlok V. Joglekar
Alok V. Joglekar
AGAvinash D. Ghanate
Avinash D. Ghanate
PCPrasad D. Chaskar
Prasad D. Chaskar
SBSharmila Bapat
Sharmila Bapat
The transcriptional repressors Snail and Slug contribute to cancer progression by mediating epithelial-mesenchymal transition (EMT), which results in tumor cell invasion and metastases. We extend this current understanding to demonstrate their involvement in the development of resistance to radiation and paclitaxel. The process is orchestrated through the acquisition of a novel subset of gene targets that is repressed under conditions of stress, effectively inactivating p53-mediated apoptosis, while another subset of targets continues to mediate EMT. Repressive activities are complemented by a concurrent derepression of specific genes resulting in the acquisition of stem cell-like characteristics. Such cells are bestowed with three critical capabilities, namely EMT, resistance to p53-mediated apoptosis, and a self-renewal program, that together define the functionality and survival of metastatic cancer stem cells. EMT provides a mechanism of escape to a new, less adverse niche; resistance to apoptosis ensures cell survival in conditions of stress in the primary tumor; whereas acquisition of “stemness” ensures generation of the critical tumor mass required for progression of micrometastases to macrometastases. Our findings, besides achieving considerable expansion of the inventory of direct genes targets, more importantly demonstrate that such elegant cooperative modulation of gene regulation mediated by Snail and Slug is critical for a cancer cell to acquire stem cell characteristics toward resisting radiotherapy- or chemotherapy-mediated cellular stress, and this may be a determinative aspect of aggressive cancer metastases. Disclosure of potential conflicts of interest is found at the end of this article.

10 June 2013 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CWChris C. Wolford
Chris C. Wolford
SMStephen J. McConoughey
Stephen J. McConoughey
SJSwati P. Jalgaonkar
Swati P. Jalgaonkar
MLMarino Leon
Marino Leon
AMAnand S. Merchant
Anand S. Merchant
THTsonwin Hai
Tsonwin Hai
Host response to cancer signals has emerged as a key factor in cancer development; however, the underlying molecular mechanism is not well understood. In this report, we demonstrate that activating transcription factor 3 (ATF3), a hub of the cellular adaptive response network, plays an important role in host cells to enhance breast cancer metastasis. Immunohistochemical analysis of patient tumor samples revealed that expression of ATF3 in stromal mononuclear cells, but not cancer epithelial cells, is correlated with worse clinical outcomes and is an independent predictor for breast cancer death. This finding was corroborated by data from mouse models showing less efficient breast cancer metastasis in Atf3-deficient mice than in WT mice. Further, mice with myeloid cell–selective KO of Atf3 showed fewer lung metastases, indicating that host ATF3 facilitates metastasis, at least in part, by its function in macrophage/myeloid cells. Gene profiling analyses of macrophages from mouse tumors identified an ATF3-regulated gene signature that could distinguish human tumor stroma from distant stroma and could predict clinical outcomes, lending credence to our mouse models. In conclusion, we identified ATF3 as a regulator in myeloid cells that enhances breast cancer metastasis and has predictive value for clinical outcomes.

23 January 2011
Verified
Book Chapter
Closed access
THTsonwin Hai
Tsonwin Hai
SJSwati Jalgaonkar
Swati Jalgaonkar
CWChristopher C. Wolford
Christopher C. Wolford
XYXin Yin
Xin Yin